Found: 9
Select item for more details and to access through your institution.
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.
- Published in:
- 2010
- By:
- Publication type:
- journal article
SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.
- Published in:
- Oncogene, 2006, v. 25, n. 37, p. 5180, doi. 10.1038/sj.onc.1209520
- By:
- Publication type:
- Article
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.
- Published in:
- Oncogene, 2006, v. 25, n. 36, p. 5056, doi. 10.1038/sj.onc.1209510
- By:
- Publication type:
- Article
BCR–ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
- Published in:
- Oncogene, 2006, v. 25, n. 7, p. 1118, doi. 10.1038/sj.onc.1209133
- By:
- Publication type:
- Article
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
- Published in:
- Oncogene, 2014, v. 33, n. 17, p. 2169, doi. 10.1038/onc.2013.169
- By:
- Publication type:
- Article
VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 1, p. 216, doi. 10.1038/leu.2013.223
- By:
- Publication type:
- Article
CD95 ligand expression as a mechanism of immune escape in breast cancer.
- Published in:
- Immunology, 2000, v. 99, n. 1, p. 69, doi. 10.1046/j.1365-2567.2000.00921.x
- By:
- Publication type:
- Article
Defining CD95 as a tumor suppressor gene.
- Published in:
- Journal of Molecular Medicine, 2000, v. 78, n. 6, p. 312, doi. 10.1007/s001090000112
- By:
- Publication type:
- Article